Related Experiment Videos

Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart

Insights

Diltiazem effectively reduces acid buildup in the heart muscle during ischemia. This study shows diltiazem enhances pH recovery after partial coronary artery occlusion, indicating its potential therapeutic benefit.

Area of Science:

  • Cardiovascular Physiology
  • Biochemistry

Background:

  • Myocardial acidosis is a consequence of reduced coronary blood flow during ischemia.
  • Understanding interventions that mitigate acidosis is crucial for managing ischemic heart conditions.

Purpose of the Study:

  • To investigate the effect of diltiazem on myocardial acidosis in a canine model of partial coronary occlusion.
  • To assess the impact of diltiazem on pH recovery and tissue metabolites during myocardial ischemia.

Main Methods:

  • Partial occlusion of the left anterior descending coronary artery in canine hearts to induce ischemia.
  • Measurement of myocardial pH using a micro glass pH electrode.
  • Intravenous administration of saline, diltiazem, or propranolol post-occlusion.

Main Results:

  • Partial occlusion significantly decreased myocardial pH from 7.53 to 6.93.
  • Diltiazem (100 µg/kg) administration resulted in a 76% increase in pH recovery, significantly potentiating spontaneous recovery.
  • Propranolol also potentiated pH recovery.
  • Myocardial acidosis correlated with increased lactate and decreased ATP and creatine phosphate levels.

Conclusions:

  • Diltiazem attenuates ischemic myocardial acidosis.
  • The drug's effect on pH is linked to alterations in myocardial energy metabolism.
  • Diltiazem demonstrates potential as a therapeutic agent for ischemic heart conditions.

Related Concept Videos